Tackling heart failure in sub-Saharan Africa: the imperious need for hypertension prevention and control
Jean Jacques Noubiap
The Pan African Medical Journal · 2020
doi:10.11604/pamj.2020.36.372.24528 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Heart failure (HF) is a leading contributor to the global burden of disease, affecting about 26 million people worldwide. It is associated with high morbidity, recurrent and prolonged hospitalization, poor quality of life, premature death and massive economic loss. Sub-Saharan African (SSA) populations are disproportionally affected. According to the International Congestive Heart Failure (INTER-CHF) prospective cohort study, patients with HF in Sub-Saharan Africa (SSA) have the highest mortality rate, with a third of them who die within a year. The excess HF-related mortality in the region is mostly attributed to weak health care systems that are already overwhelmed with the burden of infectious diseases, and to poor access to guideline-directed medical treatment. Furthermore, HF in SSA occurs at a much younger age, mostly in professionally active adults, leading to significant loss of economic productivity.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.